Cooper Hill Partners is a privately owned hedge fund sponsor.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 7, 2001
Locus Pharmaceuticals
|
Series C | $40M | Biotechnology | — |
Feb 20, 2001
Spotfire
|
Series Unknown | $15M | Analytics | — |
Dec 19, 2000
Molecular Staging
|
Series D | $41.30M | Biotechnology | — |
Nov 28, 2000
Locus Pharmaceuticals
|
Series B | $42.75M | Biotechnology | Yes |
Oct 4, 2000
Elitra Pharmaceuticals
|
Series Unknown | $22M | Biotechnology | — |
Cooper Hill Partners has had 2 exits. Cooper Hill Partners most notable exits include Spotfire , Molecular Staging
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jun 6, 2007 | Spotfire | M&A | Analytics | Detail |
Sep 27, 2004 | Molecular Staging | M&A | Biotechnology | Detail |